Hosted on MSN9d
FDA approves 'ketamine' nasal spray for depression — here's everything you need to knowA nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...
CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...
Green Matters on MSN4d
Viral Video Reveals the Right Way to Use Flonase, Because Apparently We're All Doing It WrongA doctor explains how to correctly use Flonase nasal spray, which includes manually opening your sinuses before you spray.
Inquirer on MSN5d
World’s first anti-depression nasal spray receives FDA approvalThe US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...
ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.
Fast Company on MSN18d
Johnson & Johnson ketamine-derived nasal spray gets FDA approval for depression, but JNJ stock dips on earningsSpravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral ...
Spravato is the brand name for esketamine ... Previous research cited by the FDA found that the nasal spray showed a "statistically significant effect" on severe depression compared to those ...
The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not ...
Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback